Adrienne E Shapiro MD , PhD (She/Her)
HIV/AIDS Medicine, Mycobacterial Disease
Assistant Professor, Global Health and Infectious Diseases
Join to View Full Profile
325 9th AveSeattle, WA 98104
Phone+1 206-744-5100
Dr. Shapiro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board-certified infectious diseases specialist and internal medicine physician. I have a primary care HIV clinic and attend on inpatient general medicine and infectious diseases consult services.
Education & Training
University of WashingtonFellowship, Infectious Disease, 2015 - 2019
University of California (San Francisco)Residency, Internal Medicine, 2013 - 2015
Johns Hopkins University School of MedicineClass of 2013
Certifications & Licensure
CA State Medical License 2014 - Present
WA State Medical License 2015 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- C-Reactive Protein for Tuberculosis Triage Testing Is Not the Answer for Some Populations-Did We Ask the Right Question?Adrienne E Shapiro, Ronit R Dalmat
American Journal of Respiratory and Critical Care Medicine. 2025-03-01 - Mpox in People with HIV: Prioritizing Interventions for those without HIV Viral Suppression.Rachel Bender Ignacio, Mari Kitahata, Michalina Montaño, Adrienne Shapiro
Clinical Infectious Diseases. 2025-02-07 - 1 citationsAn urgent call to address the intersection of mpox and HIV in Africa.Rachel A Bender Ignacio, Adrienne E Shapiro, Michalina A Montaño, Boghuma K Titanji
Lancet. 2024-12-14
Press Mentions
Among People with HIV, Mpox Vaccine Protects WellOctober 10th, 2024- What You Need to Know About COVID-19 VaccinesOctober 29th, 2021
- Monoclonal Antibody Treatment Highly Effective at Reducing COVID-19 HospitalizationsOctober 28th, 2021
- Join now to see all
Grant Support
- New pathways to prevention from community TB screening in South AfricaUNIVERSITY OF WASHINGTON2023–2025
- New pathways to prevention from community TB screening in South AfricaUNIVERSITY OF WASHINGTON2023–2025
- Novel clinic-based TB diagnostics and testing algorithms for persons with HIVUNIVERSITY OF WASHINGTON2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
